Caramiphenhydrogenedisilat Chemische Eigenschaften,Einsatz,Produktion Methoden

Originator

Panparnit,Geigy,US,1949

Manufacturing Process

20.8 parts of 1-phenylcyclopentyl-1-carboxylic acid chloride, obtained from the acid (cf. Am. Soc. 1934, 56, 715) by means of thionyl chloride, are dissolved in 250 parts by volume of absolute ether, then, while stirring and cooling with a mixture of common salt and ice a solution of 12 parts of diethylaminoethanol in 50 parts by volume of absolute ether is allowed to drop there into, the temperature being maintained below 0°C, whereupon stirring is continued during 2 hours at room temperature. The whole is then twice shaken out with water and once with diluted hydrochloric acid, the combined aqueous solutions are made alkaline with a potassium carbonate solution and shaken out with ether. The ethereal solution is washed with water, dried over potassium carbonate and the solvent is distilled off. The base boils at a pressure of 0.07 mm at 112°C to 115°C.
The base may then be converted to the hydrochloride or to the ethanedisulfonic acid salt (edisylate).

Therapeutic Function

Antitussive

Caramiphenhydrogenedisilat Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Caramiphenhydrogenedisilat Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shaanxi Dideu Medichem Co. Ltd	029-61856358 15229202216	1020@dideu.com	China	10004	58

---

• caramiphen hydrogen edisilate
• Caramiphen ethanedisulfonate
• 2-diethylaminoethyl 2-phenylcyclopentane-1-carboxylate
• 2-phenylcyclopentanecarboxylic acid 2-diethylaminoethyl ester
• Ethanedisulfonate
• BANIDACEBXZGNK-UHFFFAOYSA-N
• Bis[1-(carbo-β-diethylaminoethoxy)-1-phenylcyclopentane]ethanedisulfonate
• 125-86-0